Accéder au contenu
Merck

Creatine supplementation prevents the accumulation of fat in the livers of rats fed a high-fat diet.

The Journal of nutrition (2011-09-02)
Rafael Deminice, Robin P da Silva, Simon G Lamarre, Colin Brown, George N Furey, Shannon A McCarter, Alceu Afonso Jordao, Karen B Kelly, Kirst King-Jones, René L Jacobs, Margaret E Brosnan, John T Brosnan
RÉSUMÉ

The aim of the present study was to examine the effects of creatine supplementation on liver fat accumulation induced by a high-fat diet in rats. Rats were fed 1 of 3 different diets for 3 wk: a control liquid diet (C), a high-fat liquid diet (HF), or a high-fat liquid diet supplemented with creatine (HFC). The C and HF diets contained, respectively, 35 and 71% of energy derived from fat. Creatine supplementation involved the addition of 1% (wt:v) of creatine monohydrate to the liquid diet. The HF diet increased total liver fat concentration, liver TG, and liver TBARS and decreased the hepatic S-adenosylmethionine (SAM) concentration. Creatine supplementation normalized all of these perturbations. Creatine supplementation significantly decreased the renal activity of l-arginine:glycine amidinotransferase and plasma guanidinoacetate and prevented the decrease in hepatic SAM concentration in rats fed the HF diet. However, there was no change in either the phosphatidylcholine:phosphatidylethanolamine (PE) ratio or PE N-methyltransferase activity. The HF diet decreased mRNA for PPARα as well as 2 of its targets, carnitine palmitoyltransferase and long-chain acylCoA dehydrogenase. Creatine supplementation normalized these mRNA levels. In conclusion, creatine supplementation prevented the fatty liver induced by feeding rats a HF diet, probably by normalization of the expression of key genes of β-oxidation.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Guanidineacetic acid, 99%